Search research articles
Contact Us
Filters
Showing results (211-220 of 513) with videos related to
Page
of 52
Sort By:
British Journal of Cancer
|
May 10, 2024
Epithelial-mesenchymal transition induced by tumor cell-intrinsic PD-L1 signaling predicts a poor response to immune checkpoint inhibitors in PD-L1-high lung cancer
Hyein Jeong, Jaemoon Koh, Sehui Kim, et al.
Frontiers in Oncology
|
November 7, 2024
Clinical utility of circulating tumor DNA profiling in detecting targetable fusions in non-small cell lung cancer
Young-Gon Kim, Boram Lee, Changhee Ha, et al.
International Journal of Hematology
|
April 9, 2005
Influential factors for the collection of peripheral blood stem cells and engraftment in acute myeloid leukemia patients in first complete remission
Jeeyun Lee, Mark H Lee, Keon Woo Park, et al.
Cancer
|
April 24, 2015
Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma
Bhumsuk Keam, Sung-Bae Kim, Seong Hoon Shin, et al.
Journal for Immunotherapy of Cancer
|
February 14, 2023
Clonal expansion of resident memory T cells in peripheral blood of patients with non-small cell lung cancer during immune checkpoint inhibitor treatment
Hyunsu Kim, Sehhoon Park, Kyoung-Yeon Han, et al.
Cancer Science
|
August 5, 2011
Clinical significance of tumor-infiltrating FOXP3+ T cells in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma
Ki Hwan Kim, Tae Min Kim, Heounjeong Go, et al.
Cancer Immunology Research
|
September 5, 2024
Spatially Resolved Whole-Transcriptomic and Proteomic Profiling of Lung Cancer and Its Immune Microenvironment According to PD-L1 Expression
Jaemoon Koh, Dongjoo Lee, Sehui Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2018
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial
Jinhyun Cho, Hae Su Kim, Bo Mi Ku, et al.
International Journal of Cancer
|
March 13, 2026
Treatment patterns and clinical outcomes in real-world patients with small-cell lung cancer in South Korea: A single-center experience
Sehhoon Park, Danbee Kang, Jin Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 2, 2011
Clinicopathologic characteristics and outcomes of patients with anaplastic lymphoma kinase-positive advanced pulmonary adenocarcinoma: suggestion for an effective screening strategy for these tumors
Youngil Koh, Dong-Wan Kim, Tae Min Kim, et al.
Page
of 52
Search research articles
Search
Showing results (211-220 of 513) with videos related to
Sort By:
Page
of 52
British Journal of Cancer
|
May 10, 2024
Epithelial-mesenchymal transition induced by tumor cell-intrinsic PD-L1 signaling predicts a poor response to immune checkpoint inhibitors in PD-L1-high lung cancer
Hyein Jeong, Jaemoon Koh, Sehui Kim, et al.
Frontiers in Oncology
|
November 7, 2024
Clinical utility of circulating tumor DNA profiling in detecting targetable fusions in non-small cell lung cancer
Young-Gon Kim, Boram Lee, Changhee Ha, et al.
International Journal of Hematology
|
April 9, 2005
Influential factors for the collection of peripheral blood stem cells and engraftment in acute myeloid leukemia patients in first complete remission
Jeeyun Lee, Mark H Lee, Keon Woo Park, et al.
Cancer
|
April 24, 2015
Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma
Bhumsuk Keam, Sung-Bae Kim, Seong Hoon Shin, et al.
Journal for Immunotherapy of Cancer
|
February 14, 2023
Clonal expansion of resident memory T cells in peripheral blood of patients with non-small cell lung cancer during immune checkpoint inhibitor treatment
Hyunsu Kim, Sehhoon Park, Kyoung-Yeon Han, et al.
Cancer Science
|
August 5, 2011
Clinical significance of tumor-infiltrating FOXP3+ T cells in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma
Ki Hwan Kim, Tae Min Kim, Heounjeong Go, et al.
Cancer Immunology Research
|
September 5, 2024
Spatially Resolved Whole-Transcriptomic and Proteomic Profiling of Lung Cancer and Its Immune Microenvironment According to PD-L1 Expression
Jaemoon Koh, Dongjoo Lee, Sehui Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2018
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial
Jinhyun Cho, Hae Su Kim, Bo Mi Ku, et al.
International Journal of Cancer
|
March 13, 2026
Treatment patterns and clinical outcomes in real-world patients with small-cell lung cancer in South Korea: A single-center experience
Sehhoon Park, Danbee Kang, Jin Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 2, 2011
Clinicopathologic characteristics and outcomes of patients with anaplastic lymphoma kinase-positive advanced pulmonary adenocarcinoma: suggestion for an effective screening strategy for these tumors
Youngil Koh, Dong-Wan Kim, Tae Min Kim, et al.
Page
of 52